Bone/Mineral Metabolism

Top Story

Anti-osteoporosis prescription prevalence steadily decreasing in Spain

September 22, 2017

Utilization of anti-osteoporosis therapies increased by 41% from 2001 to 2006 before steadily declining by 63% during the next 7 years, according to an analysis of Spanish registry data.

“During the study period, the management of osteoporosis has undergone different revisions,” Elisa Martin-Merino, PhD, a senior epidemiologist at the Spanish Agency of Medicines and Medical Devices in Madrid, and colleagues wrote. “Apart from changes in the diagnostic criteria of osteoporosis itself and fracture risk-assessment strategies, modifications in the available pharmacological treatment happened.”

In the Journals Plus

Rates of hip fracture, subsequent 1-year mortality differ by race

September 21, 2017
The incidence of hip fracture is highest among white men and lowest among Asian men, with Asian men also experiencing lower 1-year mortality risk than white, Hispanic…
Meeting News

Romosozumab followed by denosumab decreases fracture risk in postmenopausal women

September 18, 2017
The risks for new vertebral, clinical and nonvertebral fractures were reduced and bone mineral density increased in postmenopausal women assigned romosozumab followed by…
Meeting News

HbA1c levels, diabetes duration linked to fracture risk

September 18, 2017
Adults with type 2 diabetes and obesity are at increased risk for any fracture, major osteoporotic fractures and hip fractures with longer duration of diabetes and…
More Headlines »
CME

Practical Lipidology® Volume 4, Number 1: Focus on LDL Reduction and PCSK9 Inhibition

This activity is supported by an educational grant from Amgen

A preponderance of data shows that low-density lipoprotein cholesterol (LDL-C) plays a causal role in atherosclerotic…
More »
Video
Meeting News Coverage

VIDEO: Human induced pluripotent stem cells may help study of osteoporosis, rare genetic diseases

April 8, 2016
More »
Resource Centers
CME CNE CPE CE

The Future of the Lipid Panel: An NLA Expert Discussion

This educational activity is supported by an educational grant from Quest Diagnostics, Inc.

Past-President of the National Lipid Association and Editor-in-Chief of the Journal of Clinical Lipidology, Dr. W…
More »
Advertisement
Advertisement